The panel of human breast cancer cells evaluated in this study represents a broad range of breast cancer molecular subtypes, including luminal A, luminal B, HER2-enriched, and triple negative subtypes [56,57,58,59]. The gene discussed is ERBB2; the disease is breast carcinoma.